Erste Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
42,962
+3,667
| +9% | +$1.04M | 0.1% | 177 |
|
|
2025
Q1 | $12.1M | Sell |
39,295
-7,841
| -17% | -$2.41M | 0.16% | 138 |
|
|
2024
Q4 | $17M | Buy |
47,136
+1,870
| +4% | +$673K | 0.21% | 115 |
|
|
2024
Q3 | $16.2M | Sell |
45,266
-1,784
| -4% | -$639K | 0.19% | 128 |
|
|
2024
Q2 | $14.9M | Buy |
47,050
+597
| +1% | +$190K | 0.2% | 123 |
|
|
2024
Q1 | $11.1M | Buy |
46,453
+3,664
| +9% | +$879K | 0.15% | 145 |
|
|
2023
Q4 | $9.36M | Buy |
42,789
+3,835
| +10% | +$839K | 0.14% | 152 |
|
|
2023
Q3 | $8.83M | Buy |
38,954
+1,166
| +3% | +$264K | 0.15% | 148 |
|
|
2023
Q2 | $8.3M | Buy |
37,788
+2,067
| +6% | +$454K | 0.15% | 158 |
|
|
2023
Q1 | $7.86M | Buy |
35,721
+6,280
| +21% | +$1.38M | 0.15% | 157 |
|
|
2022
Q4 | $8.14M | Buy |
29,441
+14,666
| +99% | +$4.06M | 0.17% | 150 |
|
|
2022
Q3 | $3.07M | Buy |
14,775
+252
| +2% | +$52.4K | 0.07% | 243 |
|
|
2022
Q2 | $3.46M | Buy |
14,523
+563
| +4% | +$134K | 0.08% | 243 |
|
|
2022
Q1 | $2.45M | Buy |
13,960
+1,649
| +13% | +$290K | 0.05% | 275 |
|
|
2021
Q4 | $2.65M | Buy |
12,311
+1,811
| +17% | +$389K | 0.05% | 268 |
|
|
2021
Q3 | $1.95M | Hold |
10,500
| – | – | 0.04% | 274 |
|
|
2021
Q2 | $1.86M | Buy |
+10,500
| New | +$1.86M | 0.04% | 291 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 854 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 874 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 807 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 825 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 935 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 921 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 880 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 878 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 846 |
|